Yahoo Finance | EN590 Commodities
EN590 Commodities GroupMarket Analysis 2026-06-18T16:56:35.000Z
June 18 (Reuters) - Kardigan's shares rose 1.6% in their Nasdaq debut on Thursday, after the heart drug developer raised $400 million in an upsized U.S. initial public offering. The Princeton, New Jersey-based company's shares opened at $16.25, above its IPO price of $16 per share, after Kardigan sold 25 million shares on Wednesday at the top end of its marketed range of $14 to $16. The strong market debut underscores renewed investor appetite for biotech companies with advanced clinical programs and promising drug pipelines as improving market conditions reopen the IPO window for the sector. Kardigan's debut adds to a string of successful biotech listings this year, following strong first-day performances by autoimmune disease-focused Odyssey Therapeutics, weight-loss drug de
About EN590 Commodities Group
25+ years in mineral exploration and extraction. 15+ years of global commodity trading. Based in New York, USA serving 75+ countries.